Global Small Molecule CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 248240
  • calendar_today Published On: Dec, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Small Molecule CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Small Molecule CDMO size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Small Molecule CDMO market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Small Molecule CDMO market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Development

API Production

Market segment by Application, can be divided into

Pharmaceutical

Biopharmaceutical

Market segment by players, this report covers

Lonza

Catalent

Thermo Fisher

Wuxi Apptec

PharmaBlock

Asym Chemical

Jiuzhou Pharmaceutical

Pharmaron Beijing

Porton Pharma

ChemPartner

Jiangsu Sinopep

DELPHARM

Aenova Group

Siegfried Holding AG

Recipharm AB

FAREVA SA

Almac Group

Cambrex

Charles River

CORDEN PHARMA

Jubilant Pharmova

Consort Medical

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Small Molecule CDMO product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Small Molecule CDMO, with revenue, gross margin and global market share of Small Molecule CDMO from 2019 to 2021.

Chapter 3, the Small Molecule CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Small Molecule CDMO market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Small Molecule CDMO research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Small Molecule CDMO

1.2 Classification of Small Molecule CDMO by Type

1.2.1 Overview: Global Small Molecule CDMO Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Small Molecule CDMO Revenue Market Share by Type in 2020

1.2.3 Development

1.2.4 API Production

1.3 Global Small Molecule CDMO Market by Application

1.3.1 Overview: Global Small Molecule CDMO Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Pharmaceutical

1.3.3 Biopharmaceutical

1.4 Global Small Molecule CDMO Market Size & Forecast

1.5 Global Small Molecule CDMO Market Size and Forecast by Region

1.5.1 Global Small Molecule CDMO Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Small Molecule CDMO Market Size by Region, (2016-2021)

1.5.3 North America Small Molecule CDMO Market Size and Prospect (2016-2026)

1.5.4 Europe Small Molecule CDMO Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Small Molecule CDMO Market Size and Prospect (2016-2026)

1.5.6 South America Small Molecule CDMO Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Small Molecule CDMO Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Small Molecule CDMO Market Drivers

1.6.2 Small Molecule CDMO Market Restraints

1.6.3 Small Molecule CDMO Trends Analysis

2 Company Profiles

2.1 Lonza

2.1.1 Lonza Details

2.1.2 Lonza Major Business

2.1.3 Lonza Small Molecule CDMO Product and Solutions

2.1.4 Lonza Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Lonza Recent Developments and Future Plans

2.2 Catalent

2.2.1 Catalent Details

2.2.2 Catalent Major Business

2.2.3 Catalent Small Molecule CDMO Product and Solutions

2.2.4 Catalent Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Catalent Recent Developments and Future Plans

2.3 Thermo Fisher

2.3.1 Thermo Fisher Details

2.3.2 Thermo Fisher Major Business

2.3.3 Thermo Fisher Small Molecule CDMO Product and Solutions

2.3.4 Thermo Fisher Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Thermo Fisher Recent Developments and Future Plans

2.4 Wuxi Apptec

2.4.1 Wuxi Apptec Details

2.4.2 Wuxi Apptec Major Business

2.4.3 Wuxi Apptec Small Molecule CDMO Product and Solutions

2.4.4 Wuxi Apptec Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Wuxi Apptec Recent Developments and Future Plans

2.5 PharmaBlock

2.5.1 PharmaBlock Details

2.5.2 PharmaBlock Major Business

2.5.3 PharmaBlock Small Molecule CDMO Product and Solutions

2.5.4 PharmaBlock Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 PharmaBlock Recent Developments and Future Plans

2.6 Asym Chemical

2.6.1 Asym Chemical Details

2.6.2 Asym Chemical Major Business

2.6.3 Asym Chemical Small Molecule CDMO Product and Solutions

2.6.4 Asym Chemical Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Asym Chemical Recent Developments and Future Plans

2.7 Jiuzhou Pharmaceutical

2.7.1 Jiuzhou Pharmaceutical Details

2.7.2 Jiuzhou Pharmaceutical Major Business

2.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Product and Solutions

2.7.4 Jiuzhou Pharmaceutical Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Jiuzhou Pharmaceutical Recent Developments and Future Plans

2.8 Pharmaron Beijing

2.8.1 Pharmaron Beijing Details

2.8.2 Pharmaron Beijing Major Business

2.8.3 Pharmaron Beijing Small Molecule CDMO Product and Solutions

2.8.4 Pharmaron Beijing Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Pharmaron Beijing Recent Developments and Future Plans

2.9 Porton Pharma

2.9.1 Porton Pharma Details

2.9.2 Porton Pharma Major Business

2.9.3 Porton Pharma Small Molecule CDMO Product and Solutions

2.9.4 Porton Pharma Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Porton Pharma Recent Developments and Future Plans

2.10 ChemPartner

2.10.1 ChemPartner Details

2.10.2 ChemPartner Major Business

2.10.3 ChemPartner Small Molecule CDMO Product and Solutions

2.10.4 ChemPartner Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 ChemPartner Recent Developments and Future Plans

2.11 Jiangsu Sinopep

2.11.1 Jiangsu Sinopep Details

2.11.2 Jiangsu Sinopep Major Business

2.11.3 Jiangsu Sinopep Small Molecule CDMO Product and Solutions

2.11.4 Jiangsu Sinopep Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Jiangsu Sinopep Recent Developments and Future Plans

2.12 DELPHARM

2.12.1 DELPHARM Details

2.12.2 DELPHARM Major Business

2.12.3 DELPHARM Small Molecule CDMO Product and Solutions

2.12.4 DELPHARM Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 DELPHARM Recent Developments and Future Plans

2.13 Aenova Group

2.13.1 Aenova Group Details

2.13.2 Aenova Group Major Business

2.13.3 Aenova Group Small Molecule CDMO Product and Solutions

2.13.4 Aenova Group Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Aenova Group Recent Developments and Future Plans

2.14 Siegfried Holding AG

2.14.1 Siegfried Holding AG Details

2.14.2 Siegfried Holding AG Major Business

2.14.3 Siegfried Holding AG Small Molecule CDMO Product and Solutions

2.14.4 Siegfried Holding AG Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Siegfried Holding AG Recent Developments and Future Plans

2.15 Recipharm AB

2.15.1 Recipharm AB Details

2.15.2 Recipharm AB Major Business

2.15.3 Recipharm AB Small Molecule CDMO Product and Solutions

2.15.4 Recipharm AB Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Recipharm AB Recent Developments and Future Plans

2.16 FAREVA SA

2.16.1 FAREVA SA Details

2.16.2 FAREVA SA Major Business

2.16.3 FAREVA SA Small Molecule CDMO Product and Solutions

2.16.4 FAREVA SA Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 FAREVA SA Recent Developments and Future Plans

2.17 Almac Group

2.17.1 Almac Group Details

2.17.2 Almac Group Major Business

2.17.3 Almac Group Small Molecule CDMO Product and Solutions

2.17.4 Almac Group Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Almac Group Recent Developments and Future Plans

2.18 Cambrex

2.18.1 Cambrex Details

2.18.2 Cambrex Major Business

2.18.3 Cambrex Small Molecule CDMO Product and Solutions

2.18.4 Cambrex Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Cambrex Recent Developments and Future Plans

2.19 Charles River

2.19.1 Charles River Details

2.19.2 Charles River Major Business

2.19.3 Charles River Small Molecule CDMO Product and Solutions

2.19.4 Charles River Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Charles River Recent Developments and Future Plans

2.20 CORDEN PHARMA

2.20.1 CORDEN PHARMA Details

2.20.2 CORDEN PHARMA Major Business

2.20.3 CORDEN PHARMA Small Molecule CDMO Product and Solutions

2.20.4 CORDEN PHARMA Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 CORDEN PHARMA Recent Developments and Future Plans

2.21 Jubilant Pharmova

2.21.1 Jubilant Pharmova Details

2.21.2 Jubilant Pharmova Major Business

2.21.3 Jubilant Pharmova Small Molecule CDMO Product and Solutions

2.21.4 Jubilant Pharmova Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Jubilant Pharmova Recent Developments and Future Plans

2.22 Consort Medical

2.22.1 Consort Medical Details

2.22.2 Consort Medical Major Business

2.22.3 Consort Medical Small Molecule CDMO Product and Solutions

2.22.4 Consort Medical Small Molecule CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Consort Medical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Small Molecule CDMO Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Small Molecule CDMO Players Market Share

3.2.2 Top 10 Small Molecule CDMO Players Market Share

3.2.3 Market Competition Trend

3.3 Small Molecule CDMO Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Small Molecule CDMO Revenue and Market Share by Type (2016-2021)

4.2 Global Small Molecule CDMO Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Small Molecule CDMO Revenue Market Share by Application (2016-2021)

5.2 Small Molecule CDMO Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Small Molecule CDMO Revenue by Type (2016-2026)

6.2 North America Small Molecule CDMO Revenue by Application (2016-2026)

6.3 North America Small Molecule CDMO Market Size by Country

6.3.1 North America Small Molecule CDMO Revenue by Country (2016-2026)

6.3.2 United States Small Molecule CDMO Market Size and Forecast (2016-2026)

6.3.3 Canada Small Molecule CDMO Market Size and Forecast (2016-2026)

6.3.4 Mexico Small Molecule CDMO Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Small Molecule CDMO Revenue by Type (2016-2026)

7.2 Europe Small Molecule CDMO Revenue by Application (2016-2026)

7.3 Europe Small Molecule CDMO Market Size by Country

7.3.1 Europe Small Molecule CDMO Revenue by Country (2016-2026)

7.3.2 Germany Small Molecule CDMO Market Size and Forecast (2016-2026)

7.3.3 France Small Molecule CDMO Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Small Molecule CDMO Market Size and Forecast (2016-2026)

7.3.5 Russia Small Molecule CDMO Market Size and Forecast (2016-2026)

7.3.6 Italy Small Molecule CDMO Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Small Molecule CDMO Revenue by Type (2016-2026)

8.2 Asia-Pacific Small Molecule CDMO Revenue by Application (2016-2026)

8.3 Asia-Pacific Small Molecule CDMO Market Size by Region

8.3.1 Asia-Pacific Small Molecule CDMO Revenue by Region (2016-2026)

8.3.2 China Small Molecule CDMO Market Size and Forecast (2016-2026)

8.3.3 Japan Small Molecule CDMO Market Size and Forecast (2016-2026)

8.3.4 South Korea Small Molecule CDMO Market Size and Forecast (2016-2026)

8.3.5 India Small Molecule CDMO Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Small Molecule CDMO Market Size and Forecast (2016-2026)

8.3.7 Australia Small Molecule CDMO Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Small Molecule CDMO Revenue by Type (2016-2026)

9.2 South America Small Molecule CDMO Revenue by Application (2016-2026)

9.3 South America Small Molecule CDMO Market Size by Country

9.3.1 South America Small Molecule CDMO Revenue by Country (2016-2026)

9.3.2 Brazil Small Molecule CDMO Market Size and Forecast (2016-2026)

9.3.3 Argentina Small Molecule CDMO Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Small Molecule CDMO Revenue by Type (2016-2026)

10.2 Middle East & Africa Small Molecule CDMO Revenue by Application (2016-2026)

10.3 Middle East & Africa Small Molecule CDMO Market Size by Country

10.3.1 Middle East & Africa Small Molecule CDMO Revenue by Country (2016-2026)

10.3.2 Turkey Small Molecule CDMO Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Small Molecule CDMO Market Size and Forecast (2016-2026)

10.3.4 UAE Small Molecule CDMO Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Small Molecule CDMO Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Small Molecule CDMO Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Small Molecule CDMO Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Small Molecule CDMO Revenue (USD Million) by Region (2016-2021)

Table 5. Global Small Molecule CDMO Revenue Market Share by Region (2021-2026)

Table 6. Lonza Corporate Information, Head Office, and Major Competitors

Table 7. Lonza Major Business

Table 8. Lonza Small Molecule CDMO Product and Solutions

Table 9. Lonza Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Catalent Corporate Information, Head Office, and Major Competitors

Table 11. Catalent Major Business

Table 12. Catalent Small Molecule CDMO Product and Solutions

Table 13. Catalent Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Thermo Fisher Corporate Information, Head Office, and Major Competitors

Table 15. Thermo Fisher Major Business

Table 16. Thermo Fisher Small Molecule CDMO Product and Solutions

Table 17. Thermo Fisher Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Wuxi Apptec Corporate Information, Head Office, and Major Competitors

Table 19. Wuxi Apptec Major Business

Table 20. Wuxi Apptec Small Molecule CDMO Product and Solutions

Table 21. Wuxi Apptec Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. PharmaBlock Corporate Information, Head Office, and Major Competitors

Table 23. PharmaBlock Major Business

Table 24. PharmaBlock Small Molecule CDMO Product and Solutions

Table 25. PharmaBlock Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Asym Chemical Corporate Information, Head Office, and Major Competitors

Table 27. Asym Chemical Major Business

Table 28. Asym Chemical Small Molecule CDMO Product and Solutions

Table 29. Asym Chemical Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Jiuzhou Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 31. Jiuzhou Pharmaceutical Major Business

Table 32. Jiuzhou Pharmaceutical Small Molecule CDMO Product and Solutions

Table 33. Jiuzhou Pharmaceutical Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Pharmaron Beijing Corporate Information, Head Office, and Major Competitors

Table 35. Pharmaron Beijing Major Business

Table 36. Pharmaron Beijing Small Molecule CDMO Product and Solutions

Table 37. Pharmaron Beijing Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Porton Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Porton Pharma Major Business

Table 40. Porton Pharma Small Molecule CDMO Product and Solutions

Table 41. Porton Pharma Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. ChemPartner Corporate Information, Head Office, and Major Competitors

Table 43. ChemPartner Major Business

Table 44. ChemPartner Small Molecule CDMO Product and Solutions

Table 45. ChemPartner Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Jiangsu Sinopep Corporate Information, Head Office, and Major Competitors

Table 47. Jiangsu Sinopep Major Business

Table 48. Jiangsu Sinopep Small Molecule CDMO Product and Solutions

Table 49. Jiangsu Sinopep Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. DELPHARM Corporate Information, Head Office, and Major Competitors

Table 51. DELPHARM Major Business

Table 52. DELPHARM Small Molecule CDMO Product and Solutions

Table 53. DELPHARM Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Aenova Group Corporate Information, Head Office, and Major Competitors

Table 55. Aenova Group Major Business

Table 56. Aenova Group Small Molecule CDMO Product and Solutions

Table 57. Aenova Group Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Siegfried Holding AG Corporate Information, Head Office, and Major Competitors

Table 59. Siegfried Holding AG Major Business

Table 60. Siegfried Holding AG Small Molecule CDMO Product and Solutions

Table 61. Siegfried Holding AG Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Recipharm AB Corporate Information, Head Office, and Major Competitors

Table 63. Recipharm AB Major Business

Table 64. Recipharm AB Small Molecule CDMO Product and Solutions

Table 65. Recipharm AB Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. FAREVA SA Corporate Information, Head Office, and Major Competitors

Table 67. FAREVA SA Major Business

Table 68. FAREVA SA Small Molecule CDMO Product and Solutions

Table 69. FAREVA SA Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Almac Group Corporate Information, Head Office, and Major Competitors

Table 71. Almac Group Major Business

Table 72. Almac Group Small Molecule CDMO Product and Solutions

Table 73. Almac Group Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Cambrex Corporate Information, Head Office, and Major Competitors

Table 75. Cambrex Major Business

Table 76. Cambrex Small Molecule CDMO Product and Solutions

Table 77. Cambrex Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Charles River Corporate Information, Head Office, and Major Competitors

Table 79. Charles River Major Business

Table 80. Charles River Small Molecule CDMO Product and Solutions

Table 81. Charles River Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. CORDEN PHARMA Corporate Information, Head Office, and Major Competitors

Table 83. CORDEN PHARMA Major Business

Table 84. CORDEN PHARMA Small Molecule CDMO Product and Solutions

Table 85. CORDEN PHARMA Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Jubilant Pharmova Corporate Information, Head Office, and Major Competitors

Table 87. Jubilant Pharmova Major Business

Table 88. Jubilant Pharmova Small Molecule CDMO Product and Solutions

Table 89. Jubilant Pharmova Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Consort Medical Corporate Information, Head Office, and Major Competitors

Table 91. Consort Medical Major Business

Table 92. Consort Medical Small Molecule CDMO Product and Solutions

Table 93. Consort Medical Small Molecule CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. Global Small Molecule CDMO Revenue (USD Million) by Players (2019-2021)

Table 95. Global Small Molecule CDMO Revenue Share by Players (2019-2021)

Table 96. Breakdown of Small Molecule CDMO by Company Type (Tier 1, Tier 2 and Tier 3)

Table 97. Small Molecule CDMO Players Head Office, Products and Services Provided

Table 98. Small Molecule CDMO Mergers & Acquisitions in the Past Five Years

Table 99. Small Molecule CDMO New Entrants and Expansion Plans

Table 100. Global Small Molecule CDMO Revenue (USD Million) by Type (2016-2021)

Table 101. Global Small Molecule CDMO Revenue Share by Type (2016-2021)

Table 102. Global Small Molecule CDMO Revenue Forecast by Type (2021-2026)

Table 103. Global Small Molecule CDMO Revenue by Application (2016-2021)

Table 104. Global Small Molecule CDMO Revenue Forecast by Application (2021-2026)

Table 105. North America Small Molecule CDMO Revenue by Type (2016-2021) & (USD Million)

Table 106. North America Small Molecule CDMO Revenue by Type (2021-2026) & (USD Million)

Table 107. North America Small Molecule CDMO Revenue by Application (2016-2021) & (USD Million)

Table 108. North America Small Molecule CDMO Revenue by Application (2021-2026) & (USD Million)

Table 109. North America Small Molecule CDMO Revenue by Country (2016-2021) & (USD Million)

Table 110. North America Small Molecule CDMO Revenue by Country (2021-2026) & (USD Million)

Table 111. Europe Small Molecule CDMO Revenue by Type (2016-2021) & (USD Million)

Table 112. Europe Small Molecule CDMO Revenue by Type (2021-2026) & (USD Million)

Table 113. Europe Small Molecule CDMO Revenue by Application (2016-2021) & (USD Million)

Table 114. Europe Small Molecule CDMO Revenue by Application (2021-2026) & (USD Million)

Table 115. Europe Small Molecule CDMO Revenue by Country (2016-2021) & (USD Million)

Table 116. Europe Small Molecule CDMO Revenue by Country (2021-2026) & (USD Million)

Table 117. Asia-Pacific Small Molecule CDMO Revenue by Type (2016-2021) & (USD Million)

Table 118. Asia-Pacific Small Molecule CDMO Revenue by Type (2021-2026) & (USD Million)

Table 119. Asia-Pacific Small Molecule CDMO Revenue by Application (2016-2021) & (USD Million)

Table 120. Asia-Pacific Small Molecule CDMO Revenue by Application (2021-2026) & (USD Million)

Table 121. Asia-Pacific Small Molecule CDMO Revenue by Region (2016-2021) & (USD Million)

Table 122. Asia-Pacific Small Molecule CDMO Revenue by Region (2021-2026) & (USD Million)

Table 123. South America Small Molecule CDMO Revenue by Type (2016-2021) & (USD Million)

Table 124. South America Small Molecule CDMO Revenue by Type (2021-2026) & (USD Million)

Table 125. South America Small Molecule CDMO Revenue by Application (2016-2021) & (USD Million)

Table 126. South America Small Molecule CDMO Revenue by Application (2021-2026) & (USD Million)

Table 127. South America Small Molecule CDMO Revenue by Country (2016-2021) & (USD Million)

Table 128. South America Small Molecule CDMO Revenue by Country (2021-2026) & (USD Million)

Table 129. Middle East & Africa Small Molecule CDMO Revenue by Type (2016-2021) & (USD Million)

Table 130. Middle East & Africa Small Molecule CDMO Revenue by Type (2021-2026) & (USD Million)

Table 131. Middle East & Africa Small Molecule CDMO Revenue by Application (2016-2021) & (USD Million)

Table 132. Middle East & Africa Small Molecule CDMO Revenue by Application (2021-2026) & (USD Million)

Table 133. Middle East & Africa Small Molecule CDMO Revenue by Country (2016-2021) & (USD Million)

Table 134. Middle East & Africa Small Molecule CDMO Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Small Molecule CDMO Picture

Figure 2. Global Small Molecule CDMO Revenue Market Share by Type in 2020

Figure 3. Development

Figure 4. API Production

Figure 5. Small Molecule CDMO Revenue Market Share by Application in 2020

Figure 6. Pharmaceutical Picture

Figure 7. Biopharmaceutical Picture

Figure 8. Global Small Molecule CDMO Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 9. Global Small Molecule CDMO Revenue and Forecast (2016-2026) & (USD Million)

Figure 10. Global Small Molecule CDMO Revenue Market Share by Region (2016-2026)

Figure 11. Global Small Molecule CDMO Revenue Market Share by Region in 2020

Figure 12. North America Small Molecule CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 13. Europe Small Molecule CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Asia-Pacific Small Molecule CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. South America Small Molecule CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Middle East and Africa Small Molecule CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Small Molecule CDMO Market Drivers

Figure 18. Small Molecule CDMO Market Restraints

Figure 19. Small Molecule CDMO Market Trends

Figure 20. Lonza Recent Developments and Future Plans

Figure 21. Catalent Recent Developments and Future Plans

Figure 22. Thermo Fisher Recent Developments and Future Plans

Figure 23. Wuxi Apptec Recent Developments and Future Plans

Figure 24. PharmaBlock Recent Developments and Future Plans

Figure 25. Asym Chemical Recent Developments and Future Plans

Figure 26. Jiuzhou Pharmaceutical Recent Developments and Future Plans

Figure 27. Pharmaron Beijing Recent Developments and Future Plans

Figure 28. Porton Pharma Recent Developments and Future Plans

Figure 29. ChemPartner Recent Developments and Future Plans

Figure 30. Jiangsu Sinopep Recent Developments and Future Plans

Figure 31. DELPHARM Recent Developments and Future Plans

Figure 32. Aenova Group Recent Developments and Future Plans

Figure 33. Siegfried Holding AG Recent Developments and Future Plans

Figure 34. Recipharm AB Recent Developments and Future Plans

Figure 35. FAREVA SA Recent Developments and Future Plans

Figure 36. Almac Group Recent Developments and Future Plans

Figure 37. Cambrex Recent Developments and Future Plans

Figure 38. Charles River Recent Developments and Future Plans

Figure 39. CORDEN PHARMA Recent Developments and Future Plans

Figure 40. Jubilant Pharmova Recent Developments and Future Plans

Figure 41. Consort Medical Recent Developments and Future Plans

Figure 42. Global Small Molecule CDMO Revenue Share by Players in 2020

Figure 43. Small Molecule CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 44. Global Top 3 Players Small Molecule CDMO Revenue Market Share in 2020

Figure 45. Global Top 10 Players Small Molecule CDMO Revenue Market Share in 2020

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 47. Global Small Molecule CDMO Revenue Share by Type in 2020

Figure 48. Global Small Molecule CDMO Market Share Forecast by Type (2021-2026)

Figure 49. Global Small Molecule CDMO Revenue Share by Application in 2020

Figure 50. Global Small Molecule CDMO Market Share Forecast by Application (2021-2026)

Figure 51. North America Small Molecule CDMO Sales Market Share by Type (2016-2026)

Figure 52. North America Small Molecule CDMO Sales Market Share by Application (2016-2026)

Figure 53. North America Small Molecule CDMO Revenue Market Share by Country (2016-2026)

Figure 54. United States Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Canada Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Mexico Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Europe Small Molecule CDMO Sales Market Share by Type (2016-2026)

Figure 58. Europe Small Molecule CDMO Sales Market Share by Application (2016-2026)

Figure 59. Europe Small Molecule CDMO Revenue Market Share by Country (2016-2026)

Figure 60. Germany Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. France Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. United Kingdom Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Russia Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Italy Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Asia-Pacific Small Molecule CDMO Sales Market Share by Type (2016-2026)

Figure 66. Asia-Pacific Small Molecule CDMO Sales Market Share by Application (2016-2026)

Figure 67. Asia-Pacific Small Molecule CDMO Revenue Market Share by Region (2016-2026)

Figure 68. China Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Japan Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South Korea Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. India Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Southeast Asia Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Australia Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South America Small Molecule CDMO Sales Market Share by Type (2016-2026)

Figure 75. South America Small Molecule CDMO Sales Market Share by Application (2016-2026)

Figure 76. South America Small Molecule CDMO Revenue Market Share by Country (2016-2026)

Figure 77. Brazil Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Argentina Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Middle East and Africa Small Molecule CDMO Sales Market Share by Type (2016-2026)

Figure 80. Middle East and Africa Small Molecule CDMO Sales Market Share by Application (2016-2026)

Figure 81. Middle East and Africa Small Molecule CDMO Revenue Market Share by Country (2016-2026)

Figure 82. Turkey Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Saudi Arabia Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. UAE Small Molecule CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source